These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 5746114)

  • 1. [Association of megestrol acetate and ethinyl estradiol in the therapy of dysfunctional metrorrhagia].
    Caldana PL; Barbara A; Carnevale-Arella E
    Quad Clin Ostet Ginecol; 1968 Aug; 23(8):679-89. PubMed ID: 5746114
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical and biochemical effects of megestrol acetate allone and two megestrol acetate-estrogen combinations in gynecological indications].
    Arnold M; Richter RH; Roth F
    Z Geburtshilfe Gynakol; 1969 Oct; 171(2):125-44. PubMed ID: 5355553
    [No Abstract]   [Full Text] [Related]  

  • 3. [A new association of megestrol acetate and ethinyl estradiol in gynecologic therapy. Preliminary results].
    Signorelli I; Emanueli A
    Minerva Ginecol; 1969 Apr; 21(8):512-22. PubMed ID: 5815438
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical experience with the association of megestrol acetate and ethinylestradiol].
    Lenzi G
    Minerva Ginecol; 1968 Jun; 20(12):1058-62. PubMed ID: 5706231
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical and biological experience with a new norsteroid: SH 513].
    Lévrier M
    Gynecol Prat; 1964; 15(1):29-36. PubMed ID: 5878723
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of functional dysmenorrhea; a double-blind study.
    Nakano R; Takemura H
    Acta Obstet Gynaecol Jpn; 1971 Jan; 18(1):41-4. PubMed ID: 4933978
    [No Abstract]   [Full Text] [Related]  

  • 7. [THE PROGESTOGEN MEGESTROL ACETATE. A CLINICO-GYNECOLOGICAL EVALUATION].
    OSTERGAARD E
    Ugeskr Laeger; 1964 Jul; 126():1029-38. PubMed ID: 14175752
    [No Abstract]   [Full Text] [Related]  

  • 8. [On the effectiveness of a new gestagen in the treatment of bleeding anomalies. A clinical contribution to the problem of oral gestagen therapie].
    Thewanger W
    Wien Klin Wochenschr; 1965 Jun; 77(25):468-9. PubMed ID: 5319349
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical studies with continuous and sequential therapy with megestrol acetate].
    Teter J; Ladygin E; Mackiewicz K; Radwańska E
    Ginekol Pol; 1968 May; 39(5):565-72. PubMed ID: 4877102
    [No Abstract]   [Full Text] [Related]  

  • 10. Dysfunctional uterine bleeding in adolescents.
    Strickland J; Gibson EJ; Levine SB
    J Pediatr Adolesc Gynecol; 2006 Feb; 19(1):49-51. PubMed ID: 16472730
    [No Abstract]   [Full Text] [Related]  

  • 11. Importance of the type of the progestogen in oral contraceptives.
    Eisalo A; Luukkainen T; Järvinen PA
    Acta Obstet Gynecol Scand; 1966; 45(S9):47-51. PubMed ID: 5958398
    [No Abstract]   [Full Text] [Related]  

  • 12. [Combined estrogen-progestagen-therapy in menstruation anomalies].
    Akasu F
    Arch Gynakol; 1971 Jun; 211(1):191-3. PubMed ID: 4103779
    [No Abstract]   [Full Text] [Related]  

  • 13. [Exploration and treatment of functional metrorrhagia and of menopause].
    Lambotte R
    Rev Med Liege; 1973 Feb; 28(4):124-30. PubMed ID: 4800008
    [No Abstract]   [Full Text] [Related]  

  • 14. [Thrombocyte aggregation function during hormonal hemostasis in dysfunctional uterine hemorrhages].
    Kheĭfets SN; Fadeeva NI
    Sov Med; 1979 Jul; (7):78-82. PubMed ID: 505135
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of dysfunctional uterine hemorrhage with 6-chloro-6-dehydro-17-alpha-acetoxyprogesterone].
    CASARES PONCE HJ
    Medicina (Mex); 1963 Mar; 43():136-40. PubMed ID: 14019046
    [No Abstract]   [Full Text] [Related]  

  • 16. Abnormal uterine bleeding: avoid the rush to hysterectomy.
    Hill DA
    J Fam Pract; 2009 Mar; 58(3):136-42. PubMed ID: 19284939
    [No Abstract]   [Full Text] [Related]  

  • 17. [Estrogen excretion during testosterone and progestagen therapy of dysfunctional climacteric hemorrhage].
    Aronovich AS; Manuilova IA
    Sov Med; 1969 Aug; 32(8):14-7. PubMed ID: 5381914
    [No Abstract]   [Full Text] [Related]  

  • 18. [Influence of emotions on metrorrhagia and amenorrhea during treatment with estro-progestatives].
    Gaudefroy M
    Gynecologie; 1974; 25(2):135-7. PubMed ID: 4448257
    [No Abstract]   [Full Text] [Related]  

  • 19. WITHDRAWAL AND BREAKTHROUGH BLEEDING PATTERNS ATTENDANT UPON THE USE OF CERTAIN ACETOXY PROGESTERONES.
    MAAS JM
    West J Surg Obstet Gynecol; 1963; 71():224-8. PubMed ID: 14080400
    [No Abstract]   [Full Text] [Related]  

  • 20. [Combination of 17 alpha-ethinyl-trienolone (2 mg) and 17 alpha-ethinyl-estradiol (0,050 mg) in gynecologic therapy].
    Soutoul JH
    Bull Fed Soc Gynecol Obstet Lang Fr; 1968; 20(2):191-4. PubMed ID: 5758158
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.